solid base of alternative third-party facilities to be immune to backlogs and capacity issues
Access to information is a key driver for innovative solutions. Using global association of Novel Nutrition Network Ltd. and its established contacts in China, India, Japan and US, EuroPharma brings value to locally oriented companies which can turn our innovation into their own market competitiveness.
EuroPharma selectively chooses the most innovative novel ingredients, supplied by Novel Nutrition Network Ltd. or third parties and distributes them as Core Products.
CORE PRODUCTS CATALOGUE
Clear Winner of Pending Claims List
Novel Drug Delivery : Spherosomes
Delivers up to 50x more Free Curcumin vs unformulated Curcuminoids
Liquid -> Transparent -> Red Orange -> Bioavailable -> Appealing
Pending Claims for Joints, Liver, Cardio, Digestion, Immunity, Skin
The only innovation of Generic Claim List
It is time to publicize new cardio concept: “oxidized LDL” (oxLDL)
EFSA reviewed studies show 20-30%
of blood oxLDL in 3 weeks
Available as Cardio or Vision softgel formulations
The evidence is emerging
8 fundamental human trials published in 2011-2013
Available in natural or synthetic form
(oil and powder)
Also in combinations as Calcium lozenges, vit. D3 softgels or in multivitamins
Ultra low cost per dose
Formulated 35% DHA solution
Ready to drink
Ultra low excipient load
Patent pending taste buffering technique
Available as chewable softgel, oil drops or emulsion
Phospholipid form allows for low dose (even 300mg)
Available as bulk oil, softgel and liquid hardgel
Exclusive distributor for Aker Biomarine in CE Europe
The only Yeast Probiotic available commercially
Much more durable than lactic acid bacteria
Fastest and safest remedy to Diarrhea
Regulatory status: PARNUT
Can easily compete with drug formulations in the pharmacy market
EuroPharma presents an active approach in the market, therefore each year prepares a new range of original contract manufacturing formulations and then recommends these solutions to its customers, which simultaneously develops sales of services provided by LeanPack Sp. z o.o.
We provide Quality Assurance policies within Technical Agreements signed with our clients. They are tailored to their specific requirements on traceability, workload and expenditure. The minimum range of requirements is always set by EU food safety regulations and commercial quality standards (HACCP, ISO 22 000, BRC Food, GMP).
MONITORING & ANALYSIS
All the stages of production, warehousing as well as transportation (when applicable) are monitored for temperature and humidity. Batch records and retention samples are stored in controlled conditions to assure smooth quality assessments. All routine checks as well as arbitrary analysis are made in independent GLP laboratories.
Many items from our own range of contract manufacturing formulations turn into real products under private labels on different EU markets. In such case we automatically start a stability program for those formulations, and the results are then provided free of charge to the existing private label owners and new clients, who intend to launch these formulation.
Please be informed that we have started an EU grant project entitled : ‘The implementation of new technology by purchasing of encapsulation machine with dosing system at Europharma Alliance’ financed by the European Regional Development Fund under the Regional Operational Programme for the Lower Silesia Province, Priority 1 ‘Increasing competitiveness of Lower Silesian enterprises’ Action 1.1 ‘Innovation for business’ Scheme 1.1. A2 ‘Investment subsidies for SMEs to support product and process innovation at the enterprise level (with the exception of projects in the field of tourism)’.
We are now soliciting offers for equipment as specified in attached request for offer. Please fill free to download the document and quote your offer.
Please find enclosed the specimen for submission of the offers in the project entitled : ‘The implementation of new technology by purchasing of encapsulation machine with dosing system at Europharma Alliance’ financed by the European Regional Development Fund under the Regional Operational Programme for the Lower Silesia Province, Priority 1 ‘Increasing competitiveness of Lower Silesian enterprises’ Action 1.1 ‘Innovation for business’ Scheme 1.1. A2 ‘Investment subsidies for SMEs to support product and process innovation at the enterprise level (with the exception of projects in the field of tourism)’.
Uprzejmie informujemy, że rozpoczęliśmy projekt „Wdrożenie nowej technologii poprzez zakup maszyny do kapsułkowania z systemem dozowania w firmie EuroPharma Alliance.” wspołfinansowanego ze środkow Europejskiego Funduszu Rozwoju Regionalnego w ramach Regionalnego Programu Operacyjnego dla Wojewodztwa Dolnośląskiego, Priorytet 1 „Wzrost konkurencyjności dolnośląskich przedsiębiorstw” Działalnie 1.1 „Innowacje dla przedsiębiorstw” Schemat 1.1. A2 „Dotacje inwestycyjne dla mśp wspierające innowacyjność produktową i procesową na poziomie przedsiębiorstwa (z wyłączeniem projektow z zakresu turystyki)” zwracamy się z prośbą o przedstawienie oferty na zakup maszyny do kapsułkowania z systemem dozowania. Wszelkie informacje zawarte są w dołączonym pliku PDF.